Cerqueira Nuno M F S A, Gesto Diana, Oliveira Eduardo F, Santos-Martins Diogo, Brás Natércia F, Sousa Sérgio F, Fernandes Pedro A, Ramos Maria J
UCIBIO, REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre, 4169-007 Porto, Portugal.
UCIBIO, REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Rua do Campo Alegre, 4169-007 Porto, Portugal.
Arch Biochem Biophys. 2015 Sep 15;582:56-67. doi: 10.1016/j.abb.2015.05.011. Epub 2015 Jun 1.
Computational aided drug design (CADD) is presently a key component in the process of drug discovery and development as it offers great promise to drastically reduce cost and time requirements. In the pharmaceutical arena, virtual screening is normally regarded as the top CADD tool to screen large libraries of chemical structures and reduce them to a key set of likely drug candidates regarding a specific protein target. This chapter provides a comprehensive overview of the receptor-based virtual screening process and of its importance in the present drug discovery and development paradigm. Following a focused contextualization on the subject, the main stages of a virtual screening campaign, including its strengths and limitations, are the subject of particular attention in this review. In all of these stages special consideration will be given to practical issues that are normally the Achilles heel of the virtual screening process.
计算机辅助药物设计(CADD)目前是药物发现和开发过程中的关键组成部分,因为它有望大幅降低成本和时间需求。在制药领域,虚拟筛选通常被视为顶级的CADD工具,用于筛选大型化学结构库,并将其缩减为针对特定蛋白质靶点的一组关键的潜在药物候选物。本章全面概述了基于受体的虚拟筛选过程及其在当前药物发现和开发模式中的重要性。在对该主题进行重点背景介绍之后,虚拟筛选活动的主要阶段,包括其优势和局限性,是本综述特别关注的主题。在所有这些阶段,将特别考虑通常是虚拟筛选过程薄弱环节的实际问题。